2024-09-20 - Analysis Report
## Eli Lilly and Co (LLY) Stock Analysis Report

This report analyzes Eli Lilly and Co (LLY) stock based on the provided data.

### 1. Performance Comparison with S&P 500 (VOO)

**Company Overview:** Eli Lilly and Co is a global pharmaceutical company that develops and manufactures medicines for various medical conditions.

**Cumulative Return:** LLY's cumulative return stands at 876.68, significantly outperforming the S&P 500 (VOO) with a return of 128.99.

**Performance Discrepancy:** The difference in performance between LLY and VOO is considerable. LLY has outperformed VOO by 747.69, which represents 92.77% of the maximum historical performance difference.

### 2. Recent Price Movement

**Current Price:** 906.68

**Moving Averages:**
- **5-Day Moving Average:** 918.86 
- **20-Day Moving Average:** 932.8
- **60-Day Moving Average:** 898.05

The current price is below all moving averages, suggesting potential downward pressure on the stock.

### 3. Technical Indicators

**RSI (Relative Strength Index):** 37.06, indicates the stock is currently in oversold territory.

**PPO (Percentage Price Oscillator):** -0.6, suggests a potential bearish trend.

**Delta_Previous_Relative_Divergence:** -6.86, indicates a short-term downward trend.

**Expected Return:** 58.41%, representing the maximum expected return over a 5-year period based on current investment.

### 4. Recent Earnings and Outlook

**Recent Earnings:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2023-11-02 | -0.06 | 9.50 B$ |
| 2023-08-08 | 1.96 | 8.31 B$ |
| 2024-08-08 | 1.96 | 8.31 B$ |

The most recent earnings for the quarter ending August 8th, 2024, were reported at $3.29 EPS and $11.30 billion in revenue. Unfortunately, there is no data available for the expected earnings for this quarter.

### 5. Overall Analysis Summary

LLY has consistently outperformed the S&P 500, showing strong historical growth. However, the current price is below moving averages and technical indicators suggest a potential downward trend. The RSI and PPO indicate oversold conditions. While recent earnings have been positive, the current trend suggests a potential short-term decline. Despite this, the expected return remains strong.

### 6. Recommendation

LLY is a strong company with a history of outperforming the market. However, given the current technical indicators and price action, it might be prudent to wait for a more favorable entry point before considering an investment. Further analysis should be conducted to assess the long-term prospects and potential catalysts for future growth.